Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas

Histopathology

Volumn 61, Issue 6, 2012, Pages 1043-1056

  Ushiku, Tetsuo ^a   Shinozaki Ushiku, Aya ^a   Maeda, Daichi ^a   Morita, Shigeki ^a   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alpha fetoprotein; Claudin 6; Fetal adenocarcinoma; Gastric adenocarcinoma; Germ cell tumour; Immunohistochemistry

Indexed keywords

CLAUDIN 6; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; CHORIOCARCINOMA; DIGESTIVE SYSTEM CANCER; EMBRYONAL CARCINOMA; FEMALE; FEMALE GENITAL TRACT TUMOR; FETUS; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEMINOMA; STOMACH ADENOCARCINOMA; URINARY TRACT CANCER; YOLK SAC TUMOR;

ADENOCARCINOMA; ALPHA-FETOPROTEINS; CARCINOMA, EMBRYONAL; CLAUDINS; ENDODERMAL SINUS TUMOR; FEMALE; FETUS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PHENOTYPE; SEMINOMA; STOMACH NEOPLASMS; TESTICULAR NEOPLASMS; TIGHT JUNCTIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 84870386216     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04314.x     Document Type: Article

References (38)

1. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: an overview. J. Oncol. 2010; 2010; 541957.
2. Lal-Nag M, Morin PJ. The claudins. Genome Biol. 2009; 10; 235.
3. Mineta K, Yamamoto Y, Yamazaki Y et al. Predicted expansion of the claudin multigene family. FEBS Lett. 2011; 585; 606-612.
4. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006; 6; 186.
5. Ouban A, Ahmed AA. Claudins in human cancer: a review. Histol. Histopathol. 2010; 25; 83-90.
6. Shinozaki A, Shibahara J, Noda N et al. Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch. 2011; 459; 73-80.
7. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 2005; 65; 9603-9606.
8. Kominsky SL. Claudins: emerging targets for cancer therapy. Expert Rev. Mol. Med. 2006; 8; 1-11.
9. Sullivan LM, Yankovich T, Le P et al. Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors. Am. J. Surg. Pathol. 2012; 36; 73-80.
10. Antonelli M, Hasselblatt M, Haberler C et al. Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors. Brain Pathol. 2011; 21; 558-563.
11. Birks DK, Kleinschmidt-DeMasters BK, Donson AM et al. Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors. Brain Pathol. 2010; 20; 140-150.
12. Turksen K, Troy TC. Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev. Dyn. 2001; 222; 292-300.
13. Anderson WJ, Zhou Q, Alcalde V et al. Genetic targeting of the endoderm with claudin-6CreER. Dev. Dyn. 2008; 237; 504-512.
14. Assou S, Le Carrour T, Tondeur S et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007; 25; 961-973.
15. Skotheim RI, Lind GE, Monni O et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res. 2005; 65; 5588-5598.
16. Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am. J. Surg. Pathol. 2007; 31; 836-845.
17. Kodama T, Kameya T, Hirota T et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer 1981; 48; 1647-1655.
18. Ishikura H, Kirimoto K, Shamoto M et al. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer 1986; 58; 119-126.
19. Matsunou H, Konishi F, Jalal RE, Yamamichi N, Mukawa A. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer 1994; 73; 534-540.
20. Travis WD, Brambilla E, Noguchi M et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 2011; 6; 244-285.
21. Nakatani Y, Kitamura H, Inayama Y et al. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am. J. Surg. Pathol. 1998; 22; 399-411.
22. Ushiku T, Shinozaki A, Shibahara J et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am. J. Surg. Pathol. 2010; 34; 533-540.
23. Rendon-Huerta E, Teresa F, Teresa GM et al. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas. J. Gastrointest. Cancer 2010; 41; 52-59.
24. Alagaratnam S, Lind GE, Kraggerud SM, Lothe RA, Skotheim RI. The testicular germ cell tumour transcriptome. Int. J. Androl. 2011; 34; e133-e151.
25. Cao D, Allan RW, Cheng L et al. RNA-binding protein LIN28 is a marker for testicular germ cell tumors. Hum. Pathol. 2011; 42; 710-718.
26. Liu A, Cheng L, Du J et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am. J. Surg. Pathol. 2010; 34; 697-706.
27. Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am. J. Surg. Pathol. 2009; 33; 894-904.
28. Ushiku T, Uozaki H, Shinozaki A et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci. 2009; 100; 626-632.
29. Deisch J, Raisanen J, Rakheja D. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Pediatr. Dev. Pathol. 2011; 14; 353-359.
30. Venneti S, Le P, Martinez D et al. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins. Am. J. Surg. Pathol. 2011; 35; 1463-1472.
31. Deisch J, Raisanen J, Rakheja D. Immunoexpression of SALL4 in Wilms tumors and developing kidney. Pathol. Oncol. Res. 2011; 17; 639-644.
32. Burger PC, Yu IT, Tihan T et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am. J. Surg. Pathol. 1998; 22; 1083-1092.
33. Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010; 29; 2153-2159.
34. Park JT, Chen X, Trope CG, Davidson B, Shih IeM, Wang TL. Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin. Am. J. Pathol. 2010; 177; 1087-1094.
35. DelloRusso C, Welcsh PL, Wang W, Garcia RL, King MC, Swisher EM. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol. Cancer Res. 2007; 5; 35-45.
36. Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am. J. Surg. Pathol. 2009; 33; 1065-1077.
37. Nogales FF, Preda O, Nicolae A. Yolk sac tumours revisited. A review of their many faces and names. Histopathology 2012; 60; 1023-1033.
38. Huysentruyt CJ, Vandevijver NM, Jan van Suylen R, Van de Vijver KK. Adenocarcinoma of the fetal lung-type metastatic to the ovary. Int. J. Gynecol. Pathol. 2010; 29; 339-340.